The overexpression of c-Met has been observed in various types of tumors, such as hepatocellular carcinoma [16], breast cancer [17], lung cancer [18], gastric cancer [19], colorectal cancer [20], cervical cancer [21], renal cell carcinoma [22], and pancreatic cancer [23]. The gene discussed is MET; the disease is hepatocellular carcinoma.